Elicio Therapeutics (ELTX) Operating Margin (2020 - 2022)
Elicio Therapeutics posted quarterly Operating Margin of 954.36% for Q2 2022, up 242415.0% year-on-year from N/an in Q2 2021, and down 8.58% on a QoQ basis from 878.94% in Q1 2022.
Elicio Therapeutics (ELTX) has 3 years of Operating Margin data on file, last reported at 954.36% in Q2 2022.
- For the quarter ending Q2 2022, Operating Margin rose 242415.0% year-over-year to 954.36%; the trailing twelve-month figure through Mar 2023 stood at 3946.09% (down 382848.0% YoY), and the FY2022 full-year result was 1031.42%, down 88852.0% from the prior year.
- Operating Margin for Q2 2022 stood at 954.36%, down from 878.94% in the prior quarter.
- Across five years, Operating Margin topped out at 621.63% in Q4 2020 and bottomed at 5374.39% in Q1 2021.
- The 3-year median for Operating Margin is 1079.32% (2021), against an average of 1639.49%.
- The widest annual swing landed in 2021, when Operating Margin tumbled 100966 bps; it then jumped 449545 bps in 2022.
- A 3-year view of Operating Margin shows it stood at 621.63% in 2020, then slumped by 91 bps to 58.22% in 2021, then plunged by 1739 bps to 954.36% in 2022.
- The last three Operating Margin figures came in at 954.36% (Q2 2022), 878.94% (Q1 2022), and 58.22% (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.02% |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -954.36% |
| Mar 31, 2022 | -878.94% |
| Dec 31, 2021 | 58.22% |
| Sep 30, 2021 | -1,079.32% |
| Jun 30, 2021 | -3,378.52% |
| Mar 31, 2021 | -5,374.39% |
| Dec 31, 2020 | 621.63% |
| Sep 30, 2020 | -1,400.85% |
| Jun 30, 2020 | -2,368.86% |